€57.35
0.26% yesterday
Helsinki, May 20, 04:49 pm CET
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Orion Stock price

€57.40
+8.32 16.95% 1M
+12.80 28.70% 6M
+14.62 34.17% YTD
+19.65 52.05% 1Y
+19.72 52.34% 3Y
+12.99 29.25% 5Y
+27.11 89.50% 10Y
Helsinki, Closing price Tue, May 20 2025
+0.20 0.35%
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Key metrics

Market capitalization €8.05b
Enterprise Value €8.11b
P/E (TTM) P/E ratio 23.13
EV/FCF (TTM) EV/FCF 40.13
EV/Sales (TTM) EV/Sales 5.10
P/S ratio (TTM) P/S ratio 5.07
P/B ratio (TTM) P/B ratio 7.54
Dividend yield 2.87%
Last dividend (FY25) €1.64
Revenue growth (TTM) Revenue growth 30.22%
Revenue (TTM) Revenue €1.59b
EBIT (operating result TTM) EBIT €429.00m
Free Cash Flow (TTM) Free Cash Flow €202.10m
Cash position €259.40m
EPS (TTM) EPS €2.47
P/E forward 22.91
P/S forward 4.87
EV/Sales forward 4.91
Show more

Is Orion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Orion Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Orion forecast:

5x Buy
63%
1x Hold
13%
2x Sell
25%

Analyst Opinions

8 Analysts have issued a Orion forecast:

Buy
63%
Hold
13%
Sell
25%

Financial data from Orion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,589 1,589
30% 30%
100%
- Direct Costs 611 611
11% 11%
38%
978 978
45% 45%
62%
- Selling and Administrative Expenses 271 271
6% 6%
17%
- Research and Development Expense 184 184
39% 39%
12%
523 523
83% 83%
33%
- Depreciation and Amortization 94 94
81% 81%
6%
EBIT (Operating Income) EBIT 429 429
84% 84%
27%
Net Profit 348 348
60% 60%
22%

In millions EUR.

Don't miss a Thing! We will send you all news about Orion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.

Head office Finland
CEO Aino Hurme
Employees 3,712
Founded 1917
Website www.orion.fi

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today